Isolation of <i>Candida auris</i> from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing

Simple item page
dc.contributor.authorAna Belén Araúz
dc.contributor.authorDiego H. Cáceres
dc.contributor.authorErika Santiago
dc.contributor.authorPaige A. Armstrong
dc.contributor.authorS Reynaldo Arosemena
dc.contributor.authorCarolina Ramos
dc.contributor.authorAndrés Espinosa-Bode
dc.contributor.authorJovanna Borace
dc.contributor.authorLizbeth Hayer
dc.contributor.authorIsrael Cedeño
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:54:27Z
dc.date.available2026-03-22T13:54:27Z
dc.date.issued2017
dc.descriptionCitaciones: 100
dc.description.abstractCandida auris is an emerging multidrug-resistant (MDR) fungus associated with invasive infections and high mortality. This report describes 9 patients from whom C. auris was isolated at a hospital in Panama City, Panama, the first such cases in Central America, and highlights the challenges of accurate identification and methods for susceptibility testing.
dc.identifier.doi10.1111/myc.12709
dc.identifier.urihttps://doi.org/10.1111/myc.12709
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43416
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofMycoses
dc.sourceSaint Thomas Hospital
dc.subjectCandida auris
dc.subjectPanama
dc.subjectIsolation (microbiology)
dc.subjectMedicine
dc.subjectFungus
dc.subjectIntensive care medicine
dc.subjectAntifungal
dc.subjectMicrobiology
dc.subjectBiology
dc.titleIsolation of <i>Candida auris</i> from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing
dc.typearticle

Files

Collections

Artículo Científico Publicado